» Articles » PMID: 9827787

The Value of Screening for Psychiatric Disorders in Rheumatology Referrals

Overview
Journal Arch Intern Med
Specialty General Medicine
Date 1998 Nov 25
PMID 9827787
Citations 13
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Musculoskeletal complaints are common and often unexplained and often lead to rheumatology referrals. The prevalence of psychiatric disease in patients with musculoskeletal complaints is unknown.

Objectives: To determine the prevalence of common psychiatric disorders among patients referred to a rheumatology clinic and the likelihood of establishing a rheumatic diagnosis if a psychiatric disorder is present.

Design: Prospective diagnostic survey.

Setting: Two hospital-based rheumatology clinics and a general medicine clinic.

Participants: A consecutive sample of newly referred patients (n = 185) and their rheumatologists (n = 9).

Intervention: Before their visit, all patients filled out a self-administered version of PRIME-MD (Primary Care Evaluation of Mental Disorders), a questionnaire that makes Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition: Primary Care Version, diagnoses of depressive, anxiety, and somatoform disorders. After the visit, the study rheumatologists, who were unaware of the PRIME-MD results, completed a questionnaire regarding their diagnostic assessment. These patients were compared with 210 patients with musculoskeletal complaints who were cared for in a general medicine clinic.

Main Outcome Measures: Psychiatric and rheumatic disorders.

Results: Compared with patients with musculoskeletal complaints in a general medicine clinic, patients referred to a rheumatology clinic had a higher prevalence of psychiatric disease (40% vs 29%; P = .008), had an almost 2-fold higher prevalence of anxiety disorders, and were more likely to have multiple psychiatric disorders (odds ratio = 2.70, 95% confidence interval = 1.50-5.00). The likelihood of a psychiatric disorder differed among patients with connective tissue disease, nonsystemic articular or periarticular disorders, and nonarticular disorders (27%, 38%, 55%, respectively; P = .006). In a best-fitting logistic regression model, psychiatric disorders markedly decreased the likelihood of a connective tissue disease (odds ratio = 0.24, 95% confidence interval = 0.09-0.62).

Conclusions: Forty percent of patients referred to a rheumatology clinic in this study had a psychiatric disorder, and its presence predicted a lower likelihood of a connective tissue disease. Prospective studies are needed to determine if screening for psychiatric disease before referring patients with unexplained musculoskeletal complaints would reduce costs or improve recognition of potentially treatable psychiatric disorders.

Citing Articles

Rheumatology and psychiatry: allies in times of COVID-19.

Elera-Fitzcarrald C, Huarcaya-Victoria J, Alarcon G, Ugarte-Gil M Clin Rheumatol. 2021; 40(8):3363-3367.

PMID: 34050441 PMC: 8162488. DOI: 10.1007/s10067-021-05792-7.


Mental Health Screening of Older Adults in Primary Care.

Davis M, Moye J, Karel M J Ment Health Aging. 2016; 8(2):139-149.

PMID: 27231434 PMC: 4878701.


Depression, anxiety, and quality of life in a large cohort of patients with rheumatic diseases: common, yet undertreated.

Anyfanti P, Gavriilaki E, Pyrpasopoulou A, Triantafyllou G, Triantafyllou A, Chatzimichailidou S Clin Rheumatol. 2014; 35(3):733-9.

PMID: 24859781 DOI: 10.1007/s10067-014-2677-0.


The long-term costs of traumatic stress: intertwined physical and psychological consequences.

McFarlane A World Psychiatry. 2010; 9(1):3-10.

PMID: 20148146 PMC: 2816923. DOI: 10.1002/j.2051-5545.2010.tb00254.x.


Psychological correlates of self-reported functional limitation in patients with ankylosing spondylitis.

Brionez T, Assassi S, Reveille J, Learch T, Diekman L, Ward M Arthritis Res Ther. 2009; 11(6):R182.

PMID: 19968879 PMC: 3003522. DOI: 10.1186/ar2874.